Carlos DeLecea
Vorstandsvorsitzender bei Lemus Buhils SL
Profil
Carlos DeLecea is currently the Chief Executive Officer at Lemus Buhils SL.
He previously worked as a Director at Aurum Biosciences Ltd., Head-Global Business Development at Emisphere Technologies, Inc., and VP-International & Business Development at Grupo Ferrer Internacional SA. Dr. DeLecea holds a doctorate degree from the University of Barcelona.
Aktive Positionen von Carlos DeLecea
| Unternehmen | Position | Beginn |
|---|---|---|
| Lemus Buhils SL | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Carlos DeLecea
| Unternehmen | Position | Ende |
|---|---|---|
Aurum Biosciences Ltd.
 Aurum Biosciences Ltd. Medical DistributorsDistribution Services Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Grupo Ferrer Internacional SA
 Grupo Ferrer Internacional SA Pharmaceuticals: MajorHealth Technology Grupo Ferrer Internacional SA manufactures pharmaceutical products. It offers pharmaceuticals, consumer health and vaccines. The company was founded by Carlos Ferrer Salat in 1959 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - |
| EMISPHERE TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Ausbildung von Carlos DeLecea
| University of Barcelona | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Aurum Biosciences Ltd.
Aurum Biosciences Ltd. Medical DistributorsDistribution Services Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom. | Distribution Services |
| Lemus Buhils SL | |
Grupo Ferrer Internacional SA
Grupo Ferrer Internacional SA Pharmaceuticals: MajorHealth Technology Grupo Ferrer Internacional SA manufactures pharmaceutical products. It offers pharmaceuticals, consumer health and vaccines. The company was founded by Carlos Ferrer Salat in 1959 and is headquartered in Barcelona, Spain. | Health Technology |
